DE69421721T2 - (e)-2'-deoxy-2'-(fluormethylen)cytidin-monohydrat - Google Patents

(e)-2'-deoxy-2'-(fluormethylen)cytidin-monohydrat

Info

Publication number
DE69421721T2
DE69421721T2 DE69421721T DE69421721T DE69421721T2 DE 69421721 T2 DE69421721 T2 DE 69421721T2 DE 69421721 T DE69421721 T DE 69421721T DE 69421721 T DE69421721 T DE 69421721T DE 69421721 T2 DE69421721 T2 DE 69421721T2
Authority
DE
Germany
Prior art keywords
fluoromethylene
deoxy
cytidine
monohydrate
cytidine monohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69421721T
Other languages
English (en)
Other versions
DE69421721D1 (de
Inventor
Richard Donaldson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69421721D1 publication Critical patent/DE69421721D1/de
Publication of DE69421721T2 publication Critical patent/DE69421721T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69421721T 1994-01-07 1994-12-13 (e)-2'-deoxy-2'-(fluormethylen)cytidin-monohydrat Expired - Fee Related DE69421721T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17895294A 1994-01-07 1994-01-07
PCT/US1994/014648 WO1995018815A1 (en) 1994-01-07 1994-12-13 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine

Publications (2)

Publication Number Publication Date
DE69421721D1 DE69421721D1 (de) 1999-12-23
DE69421721T2 true DE69421721T2 (de) 2000-04-27

Family

ID=22654587

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69421721T Expired - Fee Related DE69421721T2 (de) 1994-01-07 1994-12-13 (e)-2'-deoxy-2'-(fluormethylen)cytidin-monohydrat

Country Status (20)

Country Link
EP (1) EP0738273B1 (de)
JP (1) JPH09511227A (de)
KR (1) KR100330328B1 (de)
CN (1) CN1043231C (de)
AT (1) ATE186732T1 (de)
AU (1) AU684604B2 (de)
CA (1) CA2179987C (de)
DE (1) DE69421721T2 (de)
DK (1) DK0738273T3 (de)
ES (1) ES2141330T3 (de)
FI (1) FI114396B (de)
GR (1) GR3032614T3 (de)
HU (1) HU217849B (de)
IL (1) IL112242A (de)
MX (1) MX9500363A (de)
NO (1) NO306409B1 (de)
NZ (1) NZ279030A (de)
TW (1) TW397838B (de)
WO (1) WO1995018815A1 (de)
ZA (1) ZA9512B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1043324B1 (de) 1997-11-12 2004-06-16 Mitsubishi Chemical Corporation Purinderivate und medikamente, welche dieselben als aktiven bestandteil enthalten
KR100747106B1 (ko) 1999-05-11 2007-08-08 미쯔비시 가가꾸 가부시끼가이샤 퓨린 유도체 이수화물, 이를 유효성분으로 함유하는 의약및 이의 제조 중간체

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002648C (en) * 1988-11-15 2000-02-29 James R. Mccarthy 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
JPH0615557B2 (ja) * 1990-02-19 1994-03-02 ヤマサ醤油株式会社 ２’―デオキシ―２’―メチリデンシチジンの２水和物結晶
AU662630B2 (en) * 1992-05-12 1995-09-07 Aventis Inc. A process for the preparation of ribonucleotide reductase inhibitors

Also Published As

Publication number Publication date
IL112242A0 (en) 1995-03-30
HUT75055A (en) 1997-03-28
EP0738273A1 (de) 1996-10-23
AU1553295A (en) 1995-08-01
GR3032614T3 (en) 2000-05-31
EP0738273B1 (de) 1999-11-17
KR100330328B1 (ko) 2002-12-05
HU9601848D0 (en) 1996-09-30
NO962848D0 (no) 1996-07-05
NO306409B1 (no) 1999-11-01
FI962769A (fi) 1996-07-05
AU684604B2 (en) 1997-12-18
DE69421721D1 (de) 1999-12-23
IL112242A (en) 2000-08-31
ATE186732T1 (de) 1999-12-15
CN1043231C (zh) 1999-05-05
NZ279030A (en) 1997-05-26
CN1141045A (zh) 1997-01-22
CA2179987C (en) 1999-01-19
WO1995018815A1 (en) 1995-07-13
ZA9512B (en) 1995-09-11
FI114396B (fi) 2004-10-15
TW397838B (en) 2000-07-11
NO962848L (no) 1996-09-06
FI962769A0 (fi) 1996-07-05
DK0738273T3 (da) 2000-04-17
HU217849B (hu) 2000-04-28
ES2141330T3 (es) 2000-03-16
JPH09511227A (ja) 1997-11-11
MX9500363A (es) 1998-04-30
CA2179987A1 (en) 1995-07-13

Similar Documents

Publication Publication Date Title
PT755249E (pt) Utilizacao de inibidores da reaccao de maillard para o tratamento de doenca com base em amiloidose
BRPI0411900A (pt) compostos antivirais e métodos
SE9500566D0 (sv) L-plate
FI963070A0 (fi) Klooripyrimidiinivälituotteita
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
ITRM930291A0 (it) Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti.
ATE201680T1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze
DK0550532T3 (da) Dextrinsulfater som anti-HIV-1-midler og præparat indeholdende disse
DE69421721T2 (de) (e)-2'-deoxy-2'-(fluormethylen)cytidin-monohydrat
MY124071A (en) Treatment of viral disease in swine
BR9811643A (pt) Suplementação quìmica de osso
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
DE69836087D1 (de) Kortikalknochenimplantat für wirbelfusion nach smith-robinson
DK0459176T3 (da) Oligophosphater med antiviral virkning
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
SE9403861D0 (sv) Novel medicinal use
ES2085023T3 (es) Procedimientos para la produccion de zidovudina.
AR015724A1 (es) La utilizacion de un inhibidor del intercambiador entre na+ y h+ para la preparacion de un medicamento destinado al tratamiento o a la profilaxia deenfermedades del sistema nervioso central.
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.
LTIP1943A (en) Arylating agents, used in the treatment of cancerand disease caused by viral infection
BR9906931A (pt) Triazepinonas, processo para sua preparação e sua aplicação terapêutica
ATE160782T1 (de) Fluoro-nukleosid-reinigung
ITCA950008A0 (it) Impiego di combinaqzioni di analoghi di nucleosidi nella terapia delleinfezioni dell'aids.
RU94020673A (ru) Средство против вирусов герпеса
ES2116574T3 (es) 4-guanidinobutiramida para mejorar la circulacion de la sangre.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee